Clinical Trial Update: Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing intra-dermal imiquimod pretreatment with topical application versus intramuscular Hepatitis B vaccine in patients with inflammatory bo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Inflammatory Bowel Diseases

Drugs mentioned

• Hepatitis B vaccine (Hepatitis B vaccine)
• Imiquimod (topical/intantaneous dermal pretreatment) (imiquimod)

Snippet

Sponsor: The University of Hong Kong | Conditions: Inflammatory Bowel Diseases, Hepatitis B | Phase 2, Phase 3 | Status: COMPLETED